Status:
COMPLETED
Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
Gilead Sciences
Conditions:
HIV Infection Primary
Eligibility:
All Genders
18+ years
Brief Summary
The investigators propose to utilize quantitative and qualitative methodology to better understand the impact of multiple drug use (polypharmacy) on medication adherence as well as the driving forces ...
Detailed Description
Primary Endpoints: Medication adherence: The investigators will assess medication adherence at baseline and at six months using the following measures: 1. Self-reported adherence to ART using the AI...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- All patients must:
- be HIV infected
- be English speaking
- be 18 years or older
- have at least one comorbidity requiring, at least, one additional chronic medication (defined as a medication that the person needs to be taking for at least six months).
- Receiving care at North Shore University Hospital Center for AIDS Research and Treatment
- Exclusion Criteria
- Evidence of cognitive impairment that limits the ability to complete the intervention
- Terminally ill patients will be also excluded.
Exclusion
Key Trial Info
Start Date :
December 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 27 2023
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT03387397
Start Date
December 12 2017
End Date
September 27 2023
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
North Shore University Hospital Division of Infectious Diseases/ Center for AIDS Research and Treatment
Manhasset, New York, United States, 11030